PDF
Abstract
Osteoporosis is typically characterized by reduced bone mass and deterioration of microarchitecture. However, bone mineral density (BMD) does not fully account for the wide variations in skeletal fragility. In this study, we propose that matrix competence is the capacity of the mineralized extracellular matrix (ECM), the lacunar–canalicular network (LCN), and the osteocyte network to ensure material integrity, maintain network connectivity, and present appropriate cell–matrix adhesion cues. When these properties are degraded, matrix-to-signal breakdown occurs: mechanical and inflammatory inputs are no longer translated efficiently into coordinated remodeling. Research findings on bone material biology, osteocyte regulation, mechanotransduction, and osteoimmunology indicate that load-adaptive formation requires efficient signal amplification and propagation across matrix and cellular networks. During aging and unloading, the properties of collagen–mineral material decrease, LCN and osteocyte coupling decrease, and anabolic adaptation becomes blunted. Chronic low-grade inflammation and immune remodeling can further exploit altered ECM positioning and adhesion, reinforcing resorptive remodeling. We suggest that reduced matrix competence provides a tissue-level explanation for the relationships among BMD, fracture risk, and therapeutic response. This framework places matrix material properties, network structural integrity, and remodeling coordination at the center of osteoporosis phenotyping independent of BMD.
Keywords
Osteoporosis
/
Extracellular matrix remodeling
/
Matrix competence
/
Mechanotransduction
/
Osteoimmunology
/
Bone quality
/
Lacunar–canalicular network
/
Bone material properties
Cite this article
Download citation ▾
Tian-ge Xia, Yi-jie Zhang, Shao-shuo Li, Yi Zhou, Wen-yu Tian, Zhi-wei Jiang, Yang Shao, Jian-wei Wang.
Matrix Competence Failure in Osteoporosis: Mechanosensing, Osteoimmune Crosstalk, and Fragility Beyond Bone Mineral Density.
Current Medical Science 1-13 DOI:10.1007/s11596-026-00235-3
| [1] |
Morin SN, Leslie WD, Schousboe JT. Osteoporosis: a review. JAMA., 2025, 334(10): 894
|
| [2] |
Ye C, Ebeling P, Kline G. Osteoporosis. Lancet., 2025, 406(10514): 2003-2016
|
| [3] |
Khandelwal S, Lane NE. Osteoporosis. Endocrinol Metab Clin N Am., 2023, 52(2): 259-275
|
| [4] |
Hernandez CJ, van der Meulen MC. Understanding bone strength is not enough. J Bone Miner Res., 2017, 32(6): 1157-1162
|
| [5] |
Chandra A, Rajawat J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int J Mol Sci., 2021, 22(7): 3553
|
| [6] |
Curtis E, Litwic A, Cooper C, et al.. Determinants of muscle and bone aging. J Cell Physiol., 2015, 230(11): 2618-2625
|
| [7] |
Liu Z, Liang Q, Ren Y, et al.. Immunosenescence: molecular mechanisms and diseases. Sig Transduct Target Ther., 2023, 8(1): 200
|
| [8] |
Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser A Biol Sci Med Sci., 2014, 69(Suppl 1): S4-S9
|
| [9] |
Franceschi C, Garagnani P, Vitale G, et al.. Inflammaging and ‘garb-aging’. Trends Endocrinol Metab., 2017, 28(3): 199-212
|
| [10] |
Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity. Ageing Res Rev., 2021, 71 ArticleID: 101422
|
| [11] |
Coleman RE, Croucher PI, Padhani AR, et al.. Bone metastases. Nat Rev Dis Primers., 2020, 6: 83
|
| [12] |
Jackett KN, Browne AT, Aber ER, et al.. How the bone microenvironment shapes the pre-metastatic niche and metastasis. Nat Cancer., 2024, 5(12): 1800-1814
|
| [13] |
Zhang X. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer. Cancer Commun (Lond)., 2019, 39(1): 76
|
| [14] |
Hofbauer LC, Busse B, Eastell R, et al.. Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol., 2022, 10(3): 207-220
|
| [15] |
Hu W, Chen Y, Dou C, et al.. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis., 2021, 80(4): 413-422
|
| [16] |
Hoong CWS, Saul D, Khosla S, et al.. Advances in the management of osteoporosis. BMJ., 2025, 390 ArticleID: e081250
|
| [17] |
Huo S, Tang X, Chen W, et al.. Epigenetic regulations of cellular senescence in osteoporosis. Ageing Res Rev., 2024, 99 ArticleID: 102235
|
| [18] |
Onuora S. SLC26A2 deficiency, matrix stiffness and mechanotransduction linked in osteoporosis. Nat Rev Rheumatol., 2023, 19(11): 677
|
| [19] |
Na J, Yang Z, Shi Q, et al.. Extracellular matrix stiffness as an energy metabolism regulator drives osteogenic differentiation in mesenchymal stem cells. Bioact Mater., 2024, 35: 549-563
|
| [20] |
Moharrer Y, Boerckel JD. Tunnels in the rock: Dynamics of osteocyte morphogenesis. Bone., 2021, 153 ArticleID: 116104
|
| [21] |
Weinkamer R, Kollmannsberger P, Fratzl P. Towards a connectomic description of the osteocyte lacunocanalicular network in bone. Curr Osteoporos Rep., 2019, 17(4): 186-194
|
| [22] |
Yang C, Tian Y, Zhao F, et al.. Bone microenvironment and osteosarcoma metastasis. Int J Mol Sci., 2020, 21(19): 6985
|
| [23] |
Kanchanawong P, Shtengel G, Pasapera AM, et al.. Nanoscale architecture of integrin-based cell adhesions. Nature., 2010, 468(7323): 580-584
|
| [24] |
Miller AE, Hu P, Barker TH. Feeling things out: bidirectional signaling of the cell–ECM interface, implications in the mechanobiology of cell spreading, migration, proliferation, and differentiation. Adv Healthc Mater., 2020, 9(8): 1901445
|
| [25] |
Weivoda MM, Bradley EW. Macrophages and bone remodeling. J Bone Miner Res., 2023, 38(3): 359-369
|
| [26] |
Okamoto K, Takayanagi H. Effect of T cells on bone. Bone., 2023, 168 ArticleID: 116675
|
| [27] |
Anani T, Castillo AB. Mechanically-regulated bone repair. Bone., 2022, 154 ArticleID: 116223
|
| [28] |
Shoaib Z, Fan TM, Irudayaraj JMK. Osteosarcoma mechanobiology and therapeutic targets. Br J Pharmacol., 2022, 179(2): 201-217
|
| [29] |
Farr JN, Fraser DG, Wang H, et al.. Identification of senescent cells in the bone microenvironment. J Bone Miner Res., 2016, 31(11): 1920-1929
|
| [30] |
Farr JN, Kaur J, Doolittle ML, et al.. Osteocyte cellular senescence. Curr Osteoporos Rep., 2020, 18(5): 559-567
|
| [31] |
de Jong MME, Chen L, Raaijmakers MHGP, et al.. Bone marrow inflammation in haematological malignancies. Nat Rev Immunol., 2024, 24(8): 543-558
|
| [32] |
Croft AP, Campos J, Jansen K, et al.. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature., 2019, 570(7760): 246-251
|
| [33] |
Gauthier V, Kyriazi M, Nefla M, et al.. Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing. Front Immunol., 2023, 14: 1137659
|
| [34] |
Vaculík J, Braun M, Dungl P, et al.. Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis. BMC Musculoskelet Disord., 2016, 17: 308
|
| [35] |
Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature., 2014, 505(7483): 327-334
|
| [36] |
Winter S, Götze KS, Hecker JS, et al.. Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche. Leukemia., 2024, 38(5): 936-946
|
| [37] |
Willett TL, Pasquale J, Grynpas MD. Collagen modifications in postmenopausal osteoporosis: advanced glycation endproducts may affect bone volume, structure and quality. Curr Osteoporos Rep., 2014, 12(3): 329-337
|
| [38] |
Ashique AM, Hart LS, Thomas CDL, et al.. Lacunar-canalicular network in femoral cortical bone is reduced in aged women and is predominantly due to a loss of canalicular porosity. Bone Rep., 2017, 7: 9-16
|
| [39] |
Bandyopadhyay S, Duffy MP, Ahn KJ, et al.. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell., 2024, 187(12): 3120-3140.e29
|
| [40] |
Rasheed A. Niche regulation of hematopoiesis: the environment is “micro”, but the influence is large. ATVB., 2022, 42(6): 691-699
|
| [41] |
Zhou T, Gao B, Fan Y, et al.. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. Elife., 2020, 9 ArticleID: e52779
|
| [42] |
Wang L, You X, Lotinun S, et al.. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. Nat Commun., 2020, 11(1): 282
|
| [43] |
Huang M, Zhou J, Li X, et al.. Mechanical protein polycystin-1 directly regulates osteoclastogenesis and bone resorption. Sci Bull., 2024, 69(12): 1964-1979
|
| [44] |
Hu YJ, Wu X, Wang F, et al.. Piezo1-mediated mechanotransduction controls osteocyte maturation and dendrite development via a YAP-CCN-Src signaling axis. Nat Commun., 2025, 16(1): 10859
|
| [45] |
Chen S, He T, Zhong Y, et al.. Roles of focal adhesion proteins in skeleton and diseases. Acta Pharm Sin B., 2023, 13(3): 998-1013
|
| [46] |
Li J, Xu K, Cui Y, et al.. ECM1-associated miR-1260b promotes osteogenic differentiation by targeting GDI1. Acta Histochem., 2024, 126(1 ArticleID: 152133
|
| [47] |
Wei H, Xu Y, Wang Y, et al.. Identification of fibroblast activation protein as an osteogenic suppressor and anti-osteoporosis drug target. Cell Rep., 2020, 33(2 ArticleID: 108252
|
| [48] |
You J, Yellowley CE, Donahue HJ, et al.. Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow. J Biomech Eng., 2000, 122(4): 387-393
|
| [49] |
El Dr Haj AJ, Minter SL, Rawlinson SCF, et al.. Cellular responses to mechanical loading in vitro. J Bone Miner Res., 1990, 5(9): 923-932
|
| [50] |
Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech., 1994, 27(3): 339-360
|
| [51] |
Nicolella DP, Moravits DE, Gale AM, et al.. Osteocyte lacunae tissue strain in cortical bone. J Biomech., 2006, 39(9): 1735-1743
|
| [52] |
Buenzli PR, Sims NA. Quantifying the osteocyte network in the human skeleton. Bone., 2015, 75: 144-150
|
| [53] |
Mullen CA, Haugh MG, Schaffler MB, et al.. Osteocyte differentiation is regulated by extracellular matrix stiffness and intercellular separation. J Mech Behav Biomed Mater., 2013, 28: 183-194
|
| [54] |
Li M, Liu X, Tian E, et al.. The role of collagen in mechanotransduction and its influence on bone metabolic activity. Int J Biol Macromol., 2025, 318 ArticleID: 144968
|
| [55] |
Garnero P. The contribution of collagen crosslinks to bone strength. Bonekey Rep., 2012, 1: 182
|
| [56] |
Saraswathibhatla A, Indana D, Chaudhuri O. Cell-extracellular matrix mechanotransduction in 3D. Nat Rev Mol Cell Biol., 2023, 24(7): 495-516
|
| [57] |
Lv J, Sun X, Ma J, et al.. Involvement of periostin–sclerostin–Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem Biophys Res Commun., 2015, 468(4): 587-593
|
| [58] |
Gerbaix M, Vico L, Ferrari SL, et al.. Periostin expression contributes to cortical bone loss during unloading. Bone., 2015, 71: 94-100
|
| [59] |
Weyts FAA, Li YS, van Leeuwen J, et al.. ERK activation and αvβ3 integrin signaling through Shc recruitment in response to mechanical stimulation in human osteoblasts. J Cell Biochem., 2002, 87(1): 85-92
|
| [60] |
Wu XT, Sun LW, Yang X, et al.. The potential role of spectrin network in the mechanotransduction of MLO-Y4 osteocytes. Sci Rep., 2017, 7: 40940
|
| [61] |
Zhuang X, Chen Q, Liu S, et al.. In vitro evaluation of Verteporfin and exploration of TEAD palmitoylation inhibition in Piezo1-YAP/TAZ signaling and ECM remodeling. Sci Rep., 2025, 15(1): 44048
|
| [62] |
Leucht P, Monica SD, Temiyasathit S, et al.. Primary cilia act as mechanosensors during bone healing around an implant. Med Eng Phys., 2013, 35(3): 392-402
|
| [63] |
Xiao Z, Zhang S, Mahlios J, et al.. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J Biol Chem., 2006, 281(41): 30884-30895
|
| [64] |
Qiu N, Xiao Z, Cao L, et al. Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia. J Cell Sci. 2012:jcs.095893.
|
| [65] |
Temiyasathit S, Tang WJ, Leucht P, et al.. Mechanosensing by the primary cilium: deletion of Kif3A reduces bone formation due to loading. PLoS One., 2012, 7(3 ArticleID: e33368
|
| [66] |
Hoey DA, Chen JC, Jacobs CR. The primary cilium as a novel extracellular sensor in bone. Front Endocrinol., 2012, 3: 75
|
| [67] |
Tazawa K, Hoshi K, Kawamoto S, et al.. Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered. J Bone Miner Metab., 2004, 22(6): 524-529
|
| [68] |
Qing H, Ardeshirpour L, Divieti Pajevic P, et al.. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res., 2012, 27(5): 1018-1029
|
| [69] |
Yee CS, Schurman CA, White CR, et al.. Investigating osteocytic perilacunar/canalicular remodeling. Curr Osteoporos Rep., 2019, 17(4): 157-168
|
| [70] |
Tatsumi S, Ishii K, Amizuka N, et al.. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab., 2007, 5(6): 464-475
|
| [71] |
Robling AG, Niziolek PJ, Baldridge LA, et al.. Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin. J Biol Chem., 2008, 283(9): 5866-5875
|
| [72] |
Delgado-Calle J, Tu X, Pacheco-Costa R, et al.. Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor. J Bone Miner Res., 2017, 32(3): 522-535
|
| [73] |
You L, Temiyasathit S, Lee P, et al.. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone., 2008, 42(1): 172-179
|
| [74] |
Nakashima T, Hayashi M, Fukunaga T, et al.. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med., 2011, 17(10): 1231-1234
|
| [75] |
Fulzele K, Lai F, Dedic C, et al.. Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots. J Bone Miner Res., 2017, 32(2): 373-384
|
| [76] |
Giangregorio L, McCartney N. Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies. J Spinal Cord Med., 2006, 29(5): 489-500
|
| [77] |
Zerwekh JE, Ruml LA, Gottschalk F, et al.. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res., 1998, 13(10): 1594-1601
|
| [78] |
Gaudio A, Pennisi P, Bratengeier C, et al.. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab., 2010, 95(5): 2248-2253
|
| [79] |
Cervinka T, Rittweger J, Hyttinen J, et al.. Anatomical sector analysis of load-bearing tibial bone structure during 90-day bed rest and 1-year recovery: Anatomical sector analysis of tibial bone structure. Clin Physiol Funct Imaging., 2011, 31(4): 249-257
|
| [80] |
Belavy DL, Beller G, Ritter Z, et al.. Bone structure and density via HR-pQCT in 60d bed-rest, 2-years recovery with and without countermeasures. J Musculoskelet Neuronal Interact., 2011, 11(3): 215-226
|
| [81] |
de Abreu MR, Wesselly M, Chung CB, et al.. Bone marrow MR imaging findings in disuse osteoporosis. Skeletal Radiol., 2011, 40(5): 571-575
|
| [82] |
Zhang Y, Paul EM, Sathyendra V, et al.. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS One., 2011, 6(8 ArticleID: e23516
|
| [83] |
Lloyd SA, Lewis GS, Zhang Y, et al.. Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading. J Bone Miner Res., 2012, 27(11): 2359-2372
|
| [84] |
Bivi N, Pacheco-Costa R, Brun LR, et al.. Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice. J Orthop Res., 2013, 31(7): 1075-1081
|
| [85] |
Zhang D, Li X, Pi C, et al.. Osteoporosis-decreased extracellular matrix stiffness impairs connexin 43-mediated gap junction intercellular communication in osteocytes. ABBS., 2020, 52(5): 517-526
|
| [86] |
Boisvert M, Chetoui N, Gendron S, et al.. Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells. Eur J Immunol., 2010, 40(10): 2710-2719
|
| [87] |
Moretti L, Stalfort J, Barker TH, et al.. The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. J Biol Chem., 2022, 298(2 ArticleID: 101530
|
| [88] |
Gendron S, Boisvert M, Chetoui N, et al.. Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function. Immunology., 2008, 125(3): 359-369
|
| [89] |
El Azreq MA, Boisvert M, Cesaro A, et al.. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. J Immunol., 2013, 191(12): 5941-5950
|
| [90] |
El Azreq MA, Arseneault C, Boisvert M, et al.. Cooperation between IL-7 receptor and integrin α2β1 (CD49b) drives Th17-mediated bone loss. J Immunol., 2015, 195(9): 4198-4209
|
| [91] |
McHugh KP, Hodivala-Dilke K, Zheng MH, et al.. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest., 2000, 105(4): 433-440
|
| [92] |
Faccio R, Takeshita S, Zallone A, et al.. C-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest., 2003, 111(5): 749-758
|
| [93] |
Elsegood CL, Zhuo Y, Wesolowski GA, et al.. M-CSF induces the stable interaction of cFms with αVβ3 integrin in osteoclasts. Int J Biochem Cell Biol., 2006, 38(9): 1518-1529
|
| [94] |
Zou W, Kitaura H, Reeve J, et al.. Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol., 2007, 176(6): 877-888
|
| [95] |
Zhao H, Kitaura H, Sands MS, et al.. Critical role of β3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res., 2005, 20(12): 2116-2123
|
| [96] |
Lane NE, Yao W, Nakamura MC, et al.. Mice lacking the integrin β5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. J Bone Miner Res., 2005, 20(1): 58-66
|
| [97] |
Liu L, Zong C, Li B, et al.. The interaction between β1 integrins and ERK1/2 in osteogenic differentiation of human mesenchymal stem cells under fluid shear stress modelled by a perfusion system: β1 integrins ERK1/2 in osteogenic differentiation of hMSCs under FSS. J Tissue Eng Regen Med., 2014, 8(2): 85-96
|
| [98] |
Meyers VE, Zayzafoon M, Gonda SR, et al.. Modeled microgravity disrupts collagen I/integrin signaling during osteoblastic differentiation of human mesenchymal stem cells. J Cell Biochem., 2004, 93(4): 697-707
|
| [99] |
Pagnotti GM, Styner M, Uzer G, et al.. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat Rev Endocrinol., 2019, 15(6): 339-355
|
| [100] |
Estell EG, Le PT, Vegting Y, et al.. Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo. Elife., 2020, 9 ArticleID: e58172
|
| [101] |
Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int., 1995, 56(2): 123-129
|
| [102] |
Dole NS, Mazur CM, Acevedo C, et al.. Osteocyte-intrinsic TGF-β signaling regulates bone quality through perilacunar/canalicular remodeling. Cell Rep., 2017, 21(9): 2585-2596
|
| [103] |
Freitas-Rodríguez S, Folgueras AR, López-Otín C. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond. Biochim Biophys Acta BBA Mol Cell Res., 2017, 1864(11): 2015-2025
|
| [104] |
Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol., 2012, 8(3): 133-143
|
| [105] |
Pajarinen J, Lin T, Gibon E, et al.. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials., 2019, 196: 80-89
|
| [106] |
Brunet A, Goodell MA, Rando TA. Ageing and rejuvenation of tissue stem cells and their niches. Nat Rev Mol Cell Biol., 2023, 24(1): 45-62
|
| [107] |
Zhang X, Cao D, Xu L, et al.. Harnessing matrix stiffness to engineer a bone marrow niche for hematopoietic stem cell rejuvenation. Cell Stem Cell., 2023, 30(4): 378-395.e8
|
| [108] |
Wan Z, Shin LY, Wang YF, et al.. Role of skeletal macrophages in fracture repair: a systematic review. Biomed Rep., 2020, 13(6): 53
|
| [109] |
Chow SK, Wong CH, Cui C, et al.. Modulating macrophage polarization for the enhancement of fracture healing, a systematic review. J Orthop Translat., 2022, 36: 83-90
|
| [110] |
Hemmatian H, Bakker AD, Klein-Nulend J, et al.. Aging, osteocytes, and mechanotransduction. Curr Osteoporos Rep., 2017, 15(5): 401-411
|
| [111] |
Qi Z, Luo J, Xiao Z, et al.. Functional roles of immune cells in osteoporosis. Front Immunol., 2025, 16: 1698283
|
| [112] |
Cosman F, Lewiecki EM, et al.. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024. J Bone Miner Res., 2024, 39(10): 1393-1405
|
| [113] |
Cosman F, Crittenden DB, Adachi JD, et al.. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med., 2016, 375(16): 1532-1543
|
| [114] |
Willett TL, Voziyan P, Nyman JS. Causative or associative: a critical review of the role of advanced glycation end-products in bone fragility. Bone., 2022, 163 ArticleID: 116485
|
| [115] |
Drake MT, Clarke BL, Oursler MJ, et al.. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev., 2017, 38(4): 325-350
|
| [116] |
Abar O, Dharmar S, Tang SY. The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone. Bone Joint Res., 2018, 7(1): 105-110
|
| [117] |
LLabre JE, Sroga GE, Tice MJL, et al. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: an in vivo and in vitro approach. Bone. 2022;156:116302.
|
| [118] |
Lin W, Li Y, Qiu C, et al. Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics. Nucleic Acids Res. 2025;53(2):gkae1298.
|
Funding
National Natural Science Foundation of China(82405520)
Jiangsu Province Traditional Chinese Medicine Science and Technology Development Program(QN202322)
Jiangsu Commission of Health(MQ2025033)
Wang Jianwei Famous Traditional Chinese Medicine Doctor Studio
RIGHTS & PERMISSIONS
The Author(s), under exclusive licence to the Huazhong University of Science and Technology
Just Accepted
This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.